Research and Markets: Europe Glioblastoma Market Highlights - 2014

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/m37sf4/europe) has announced the addition of the "Europe Glioblastoma Market Highlights - 2014" report to their offering.

The latest research, 'Europe Glioblastoma Market Highlights - 2014', provides glioblastoma market analysis, competitive landscape, and glioblastoma drug sales forecast for Germany, France, Italy, Spain, and UK.

The research includes Europe (Germany, France, Italy, Spain, and UK) glioblastoma market size estimates for 2013, market share forecast for six years to 2019, glioblastoma drugs market share, glioblastoma drugs sales estimates, glioblastoma drugs sales forecast, and glioblastoma late stage pipeline products.

This research helps executives track competitor drugs sales and market share in Europe glioblastoma market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the Europe glioblastoma market.

SCOPE OF THE REPORT

  • Identify drugs marketed in Europe for treating glioblastoma including trade name, molecule name, company, and year of launch.
  • Find out estimates for Europe glioblastoma market size in 2013, key products and their sales, and how the market and products advanced from 2010. You will benefit from our accurate country and indication level valuation of products and the market.
  • You will know the market share of leading glioblastoma brands in Europe, including generics share.
  • Find out pipeline products in clinical trial phase 3 and phase 2 for the treatment of glioblastoma. Our coverage includes molecule, mechanism of action, and the originator.
  • Gain insights into how Europe glioblastoma market will advance along with market forecast till 2019. Determine future market events and trends including launch of new drugs and generic erosion of leading molecules.
  • Find out how glioblastoma drugs will be positioned in Europe in 2019, with drug sales forecast and drug market share analysis for both marketed products and pipeline products.

Highlights of the Research:

  • Marketed Glioblastoma Drugs in Europe
  • Europe Glioblastoma Market Analysis
  • Glioblastoma Drugs Sales Analysis in Europe
  • Competitive Landscape in Europe Glioblastoma market
  • Glioblastoma Late Stage Pipeline
  • Europe Glioblastoma Market Forecast
  • Glioblastoma Drugs Sales Forecast in Europe
  • Future Competitive Landscape

Key Topics Covered:

1. Glioblastoma - Disease Definition

2. Marketed Glioblastoma Drugs in Europe

3. Europe Glioblastoma Market Analysis

4. Competitive Landscape in Europe Glioblastoma Market

5. Europe Glioblastoma Market - Future Market Outlook

For more information visit http://www.researchandmarkets.com/research/m37sf4/europe

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals